The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...
The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for ...
(Reuters) - The U.S. government will consider opportunities to "bring greater transparency" for the Medicare drug price ...
Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...
The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...
Through the issuance of Inauguration Day executive orders, the Trump Administration signaled its apparent intent to tackle ...
Democrats sought answers from RFK Jr. on how the Trump administration would handle Medicare price negotiations after a short ...
Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.
The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...
The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.